Announcements

Artificial Intelligence as a Tool to Predict Disease Progression and Treatment Response

New Study Supported by International Progressive MS Alliance Emphasizes Patient Engagement in Scientific Research from Study Design to Publication

Alliance-funded Research at ECTRIMS: Focus on Progressive MS

Alliance Remembers Professor Giancarlo Comi

Results Announced of “BTK Inhibitor” Tolebrutinib: Delays Time to Disease Progression in Secondary Progressive MS

Experimental Medicine Trials in Multiple Sclerosis Research Funding Opportunity

International Progressive MS Alliance Announces over €4.6 million in New Funding to Accelerate the Development of New Treatments for Progressive MS

Researchers Engineer a Probiotic to Reduce Destructive Immune Activity in Mice

Survey of People Affected by MS Launched to Understand the Importance of Being Actively Involved in Research

Load more